Tvardi Therapeutics Inc (TVRD) returns
Tvardi Therapeutics returns over 10 years
$1,000 invested in Tvardi Therapeutics ten years ago was worth $3.23 at the close on October 30, 2026, with dividends reinvested: an average return of -43.6% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -36.6% | — | $634.24 | -0.9% |
| 3 months | -62.2% | — | $377.52 | +2.1% |
| Year to date | -81.6% | — | $184.37 | +11.7% |
| 1 year | -83.0% | — | $170.13 | +12.4% |
| 3 years | -98.1% | -73.4% | $18.82 | +88.5% |
| 5 years | -99.9% | -73.5% | $1.31 | +76.0% |
| 10 years | -99.7% | -43.6% | $3.23 | +316.6% |
Tvardi Therapeutics return by calendar year
| Year | TVRD | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -81.6% | +11.7% | -93.3% |
| 2025 | -76.6% | +17.7% | -94.3% |
| 2024 | -31.4% | +24.9% | -56.2% |
| 2023 | -93.1% | +26.2% | -119.3% |
| 2022 | -11.8% | -18.2% | +6.3% |
| 2021 | -19.5% | +28.7% | -48.2% |
| 2020 | -6.1% | +18.4% | -24.5% |
| 2019 | +23.9% | +31.2% | -7.3% |
| 2018 | +6.2% | -4.6% | +10.8% |
| 2017 | +31.8% | +21.7% | +10.1% |
| 2016 | -44.9% | +12.0% | -56.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: TVRD financials
No forecast, no recommendation. This page describes Tvardi Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.